TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 2 January 18, 2011
(The next issue will be on February 1, 2011)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
UPCOMING MEETINGS & EVENTS
The 2011 FASEB Summer Research Conference on "Proteases in Hemostasis and Vascular Biology" will be held at the Carefree Resort in Carefree, Arizona USA from June 12-17th, 2011. For more information, go to: http://src.faseb.org/
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1HkUy8K0ura1xqT_uicICtg/
Di Marzio I, Iuliani O, Malizia R, Rolandi G, Sanna S, Castaman G, Dragani A (2011) Successful use of recombinant FVIIa in combined factor V and FVIII deficiency with surgical bleeding resistant to substitutive treatment. A case report. Haemophilia 17:160-161.
http://www.ncbi.nlm.nih.gov/pubmed/21199187
Hebert PC, Fergusson D, Stanbrook MB (2011) Off-label use of recombinant factor VIIa: why we need better drug monitoring. CMAJ 183:26-27.
http://www.ncbi.nlm.nih.gov/pubmed/21220460
Jankowski M, Undas A, Kaczmarek P, Butenas S (2011) Activated factor XI and tissue factor in chronic obstructive pulmonary disease: Links with inflammation and thrombin generation. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21236471
Knudsen T, Kjelgaard-Hansen M, Tranholm M, Wiinberg B, Clausen JT, Hansen JJ, . . . Kristensen AT (2011) Canine specific ELISA for coagulation factor VII. Vet J.
http://www.ncbi.nlm.nih.gov/pubmed/21216638
Koncar IB, Davidovic LB, Savic N, Sindelic RB, Ilic N, Dragas M, . . . Kostic D (2011) Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery, comparative study with history group. J Vasc Surg.
http://www.ncbi.nlm.nih.gov/pubmed/21215579
Kwon MJ, Yoo KY, Lee KO, Kim SH, Kim HJ (2011) Recurrent mutations and genotype-phenotype correlations in hereditary factor VII deficiency in Korea. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21206266
Latchamsetty R, Gautam S, Bhakta D, Chugh A, John RM, Epstein LM, . . . Jongnarangsin K (2011) Management and Outcomes of Cardiac Tamponade during Atrial Fibrillation Ablation in the Presence of Therapeutic Anticoagulation with Warfarin. Heart Rhythm.
http://www.ncbi.nlm.nih.gov/pubmed/21236362
Livnat T, Martinowitz U, Zivelin A, Rima D, Kenet G (2011) A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor. Thromb Haemost 105.
http://www.ncbi.nlm.nih.gov/pubmed/21225093
Logan AC, Goodnough LT (2010) Recombinant Factor VIIa: An Assessment of Evidence Regarding Its Efficacy and Safety in the Off-Label Setting. Hematology Am Soc Hematol Educ Program 2010:153-159.
http://www.ncbi.nlm.nih.gov/pubmed/21239786
Ma S, Chan YP, Kwan PS, Lee TK, Yan M, Tang KH, . . . Chan KW (2011) MicroRNA-616 Induces Androgen-Independent Growth of Prostate Cancer Cells by Suppressing Expression of Tissue Factor Pathway Inhibitor TFPI-2. Cancer Res 71:583-592.
http://www.ncbi.nlm.nih.gov/pubmed/21224345
Maroney SA, Cooley BC, Ferrel JP, Bonesho CE, Mast AE (2011) Murine Hematopoietic Cell Tissue Factor Pathway Inhibitor Limits Thrombus Growth. Arterioscler Thromb Vasc Biol.
http://www.ncbi.nlm.nih.gov/pubmed/21233452
Maroney SA, Mast AE (2011) Tissue factor pathway inhibitor and bacterial infection. J Thromb Haemost 9:119-121.
http://www.ncbi.nlm.nih.gov/pubmed/21210950
Montgomery RR, Shi Q (2010) Alternative strategies for gene therapy of hemophilia. Hematology Am Soc Hematol Educ Program 2010:197-202.
http://www.ncbi.nlm.nih.gov/pubmed/21239794
Pan JJ, Shi HM, Luo XP, Ma D, Li Y, Zhu J, . . . Li J (2010) Recombinant TFPI-2 enhances macrophage apoptosis through upregulation of Fas/FasL. Eur J Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/21192924
Plesner B, Westh P, Nielsen AD (2011) Biophysical characterisation of GlycoPEGylated recombinant human factor VIIa. Int J Pharm.
http://www.ncbi.nlm.nih.gov/pubmed/21236324
Plesner B, Westh P, Nielsen AD (2011) The effect GlycoPEGylation on the physical stability of human rFVIIa with increasing calcium chloride concentration. Eur J Pharm Biopharm.
http://www.ncbi.nlm.nih.gov/pubmed/21220008
Ruszkowska B, Gadomska G, Bielis L, Gruszka M, Goralczyk B, Rosc D, Odrowaz-Sypniewska G (2011) Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy. J Zhejiang Univ Sci B 12:12-17.
http://www.ncbi.nlm.nih.gov/pubmed/21194181
Tokodai K, Goto M, Inagaki A, Nakanishi W, Ogawa N, Satoh K, . . . Satomi S (2010) Attenuation of cross-talk between the complement and coagulation cascades by C5a blockade improves early outcomes after intraportal islet transplantation. Transplantation 90:1358-1365.
http://www.ncbi.nlm.nih.gov/pubmed/21197712
Vojacek J, Sevcikova H, Sevcik R, Bis J, Pecka M (2010) Increased platelet residual activity in patients treated with acetosalicylic acid is associated with increased tissue factor and decreased tissue factor pathway inhibitor plasma levels. Int J Cardiol.
http://www.ncbi.nlm.nih.gov/pubmed/21194769
Yu J, Zhao J, Liu W, Ge Z, Du Y (2011) Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction. Heart Vessels.
http://www.ncbi.nlm.nih.gov/pubmed/21229253
Zaman FS, Mast AE, Hall CL (2010) Evaluating surface bound rTFPI through an in vitro model of vessel wall injury. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21195461
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
